Neuro-Degenerative Disease
87
21
25
34
Key Insights
Highlights
Success Rate
83% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
8.0%
7 terminated out of 87 trials
82.9%
-3.6% vs benchmark
2%
2 trials in Phase 3/4
9%
3 of 34 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 34 completed trials
Clinical Trials (87)
100-Year Human Aging Study
Walking and Thinking - Brain Activity During Complex Walking in Stroke
The Neurodevelopmental and Behavioral Phenotyping Screening Protocol
Dyadic Mindfulness for People With Parkinson's Disease and Their Caregivers
Tracking and Predicting How Brain Damage Spreads in Neurodegenerative Diseases
ADAI - Home Care in Intelligent Environments Clinical Care Ecosystem for the Management of Home Digital Therapies Through the Use of Assistive Robots and Clinical Predictive Systems Based on Artificial Intelligence Systems
A Phase 3 Study of NTLA-2001 in ATTRv-PN
DIV-AD BARCELONA: Alzheimer's Blood-Based Biomakers for a Diverse Community
3D Printers for Autonomy in the Care of Inpatients in Continuing and Rehabilitation Care
Exploring the Olfactory Mucosa, Blood and Urine for the Identification of Early Biomarkers of Parkinson's Disease, Atypical Parkinsonisms and Neurocognitive Disorders Due to Lewy Body Disease
Cross Cultural Validation of the Italian Version of the Clinical Assessment of Dysphagia in Neurodegeneration
Understanding How Gut and Brain Barriers Are Linked to Inflammation in Obesity
Kamlanoflast In Amyotrophic Lateral Sclerosis
Retinal Imaging in Neurodegenerative Disease
Deciphering the Effect of Moderate Wine Consumption on Healthy Aging Through Postprandial Extracellular Vesicles.
A Prospective Natural History and Outcome Measure Discovery Study of Charcot-Marie-Tooth Disease, Type 4J
Brain Health Registry: An Online Registry to Identify and Assess Subjects for Brain Research
Eccentric Cycling in Multiple Sclerosis Rehabilitation
[18F]NIDF PET Imaging in Tau-related Diseases
A Biomarker-chip Assay in Preserved Red Blood Cells for the Diagnosis of Alzheimer's Disease